Proteogenomics: DNA-to-Peptide Neoantigen Explorer (2D)

2D central dogma: scrolling sequence tracks, codon table, peptide, trypsin digest and a toy MHC anchor score.

Switch to 3D

Presets

Playback

Variant

Pick a position with the slider (or click the DNA in 3D / the sequence in 2D) and the new base.

Mass spectrometry and presentation

Illustrative settings: the toy score is not an affinity predictor.

Animation

Layers

Model checks

The science

Central dogma. DNA is copied to messenger RNA by RNA polymerase. The polymerase reads the template strand 3'→5' and builds the mRNA 5'→3', so the mRNA equals the coding strand with U in place of T. Ribosomes read the mRNA in non-overlapping triplets; each of the 61 sense codons is matched by a tRNA anticodon and the 3 stop codons end the chain. Because 61 codons code for 20 amino acids the code is degenerate: a base change is silent (same amino acid), missense (different residue), nonsense (premature stop) or removes the start codon.

Trypsin cuts after Lys (K) or Arg (R) unless the next residue is Pro (Keil rule). Peptide monoisotopic mass is M = Σ mresidue + m(H2O) and an ion with charge z is seen at m/z = (M + z·1.00728)/z. A variant is visible to a mass spectrometer in a proteogenomic search only if the changed residue sits on a tryptic peptide of workable length and m/z; a new K/R can create a variant-specific peptide while a lost K/R merges two peptides.

MHC class I presentation (toy model). Class I molecules bind 8-11-mers; for an HLA-A*02-like groove the 2nd and last residues are anchors (Leu/Met at P2, Val/Leu at P9). Here a 9-mer score is the sum of position terms S = Σp wp(ap) with large anchor terms and a weak hydropathy term, turned into a presentation score 1/(1+exp(-(S-S0)/0.7)). This is a teaching toy, not a predictor: real tools (e.g. NetMHCpan) are trained on thousands of measured peptides, include proteasome cleavage and TAP transport, and every patient carries different HLA alleles.

Simplifications. One 93-nt demo gene (KRAS residues 1-30 plus a stop), one substitution at a time, no introns or splicing, no UTRs, one transcript, fixed expression and allele-fraction sliders, monoisotopic masses with no modifications. The «candidate score» = presentation x variant allele fraction x saturating expression is an illustrative ranking, not a clinical measure. Educational use only; not medical advice.

What to try

  • Press KRAS G12D: Gly12 becomes Asp. The tryptic peptide LVVVGAGDVGK gains +58.005 Da and the 9-mer score changes.
  • Choose Silent: the mRNA changes but the peptide, masses and scores do not (degeneracy).
  • Choose Nonsense: the ribosome stops at codon 22 and the peptide is truncated.
  • Try Anchor created (G13>V): Val at the last position of a 9-mer is a strong anchor, so the mutant 9-mer jumps over the threshold while the wild-type one stays below, a toy neoantigen. Anchor lost (T2>P) does the opposite.
  • Try New cleavage site (G10>R): a new Arg adds a tryptic cut; raise missed cleavages to see merged peptides return.
  • Move the nucleotide slider and click the four bases to scan every possible single-base change.
What to try
Toy presentation score of every 9-mer window (wild type vs variant)
Tryptic peptides as a simulated mass spectrum
Position terms of the best variant 9-mer vs its wild-type partner
Effect of the chosen base at each of the 93 positions